Today’s top gainers include the company CR Bard Inc. (NYSE:BCR) which is in the industry Medical Instruments & Supplies, gaining 2.01% today. In the last week its performance is 1.64%, and -3.34% for the past quarter. Currently, CR Bard Inc., BCR has a target price of 241.86, so today’s gain of 2.01% is a significant step towards its target price. The GAP today is therefore 0.30%.
CR Bard Inc. (NYSE:BCR), has a market cap of 16831.3, and is based in USA. Insider ownership is at 0.30%, and institutional ownership is 90.60%.
At the current price of 227.45, it has a dividend yield of 0.46%, and its target price is 241.86. This is with a profit margin of 9.10%, and total debt/equity of 1.01. CR Bard Inc. (NYSE:BCR) has a P/E of 44.92, as well as a forward P/E of 20.08.
With a current EPS of 5.06, and a forecasted EPS growth for next year at 11.43%,CR Bard Inc. (NYSE:BCR) has had a EPS growth for the past five years at -19.80%. For the next five years EPS growth is projected to be 10.87%.
Performance for the year is 22.42%. Since its IPO date on 4/6/1983, the total performance to date is 20.50%.
Volume today for CR Bard Inc. (NYSE:BCR), is 515300, while its average volume is 457.72. Whilst the total gain today was 2.01%, it did have a day high of -1.96%.
Volatility for this week has been at 1.45%, and 1.46% for the month. The 52-week low for CR Bard Inc., BCR has been 32.55%, while the 52-week-high has reached -4.90%.
Looking at its return of investments, which is 6.40%, and its return on assets is 6.30%. CR Bard Inc. (NYSE:BCR) has an operating margin of 14.10%. With a sales growth of -44.50% quarter over quarter. Bearing in mind that CR Bard Inc., BCR is in the sector Healthcare, its long-term debt/equity is 1.01, and has a current ratio of 2.4 and 1.9 for quick ratio.
So what is the value of CR Bard Inc.? Well its PEG is 4.13, and the P/S is 4.75, along with a P/B of 10.34. Meanwhile it has a p/cash of 21.1.